Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
VVOS•Definitive agreements signed for regional sleep center
Aug. 28 (Reuters) - Vivos Therapeutics Inc. VVOS.O:
- Vivos Therapeutics and South Palm Cardiovascular Associates signed definitive agreements to launch a regional sleep testing and treatment center.
- Vivos Therapeutics expects to hold a 75% majority interest in AIM Florida.
- The center is expected to begin treating patients and generating revenue in Q1 2027.
Source text: ID:nGNX9bYsKC
Further company coverage: VVOS.O
